Milena Murray, Pharm.D., M.S.

Associate Professor
Downers Grove, IL

Home / Academics / Our Faculty / Milena Murray, Pharm.D., M.S.


Milena Murray is currently an Associate Professor of Pharmacy Practice at Midwestern University Chicago College of Pharmacy and an HIV/ID Clinical Pharmacist at the Northwestern ID Center. She completed her Doctor of Pharmacy degree at the Philadelphia College of Pharmacy and her Masters of Science in Clinical Investigation at Northwestern University. Her post-graduate training consisted of a PGY-1 Pharmacy Residency at Maimonides Medical Center in Brooklyn, NY and an Infectious Diseases Pharmacotherapy Fellowship at Northwestern Memorial Hospital through Midwestern University. Her primary research interests are drug shortages and HIV/Hepatitis C pharmacotherapy.


Dr Murray currently serves on the Northern Illinois Society of Health-System Pharmacists Executive Board and the American Academy of HIV Medicine National Board of Directors. She is also very engaged with the Society of Infectious Diseases Pharmacists. Dr Murray is a Board Certified Infectious Diseases Pharmacist and an AAHIVM HIV Pharmacist.

Associate Professor

Downers Grove, IL

Chicago College of Pharmacy

Pharmacy Practice


Call My


Send Me
a Message


Northwestern University | 2013 | M.S.
Philadelphia College of Pharmacy | 2009 | Pharm.D.

Courses Taught

Clinical Pharmacokinetics (PPRA 1793)


HIV Pharmacotherapy: Patients who are living with HIV are often excluded from clinical trials. There is usually a lack of clinical evidence regarding these patients for certain disease states and HIV medications often interact with other disease states or maintenance medications. These projects focus on collecting evidence of how outcomes for patients living with HIV might differ from those not living with HIV.

Drug Shortages: Many times when there is a drug shortage, an alternative medication must be used. This alternative agent may have less efficacy and/or more toxic effects. These projects collect evidence regarding patients that received alternatives when the drug of choice during a drug shortage was unavailable. As the issue of drug shortages is unlikely to resolve in the near future, it is imperative that intuitions have management and ethics protocols. These projects may include surveys of drug shortage mitigation or "how-to" documents to disseminate appropriate management techniques of shortages.


Full Bibliography

Mathur S, Roberts-Toler C, Tassiopoulos K, Goodkin K, McLaughlin M, Koletar S, Erlandson KM. Demographic factors and clinical outcomes associated with mental health medication use in people living with HIV. J Acquir Immune Defic Syndr. 2019;82(1):88-95.

Shaw BG, Masic I, Gorgi N, Kalfayan N, Gilbert EM, Barr VO, Ison MG, McLaughlin MM. Appropriateness of beta-lactam allergy record updates after an allergy service consult. J Pharm Pract. 2018 Sep 4 [Epub ahead of print]

McLaughlin M, Kalfayan N, Grant J, Hawkins C, Cottreau J, Palella FJ, Stosor V. Time requirements for acquisition of hepatitis C virus therapy in HIV/HCV co-infected patients. J Pharm Tech. 2018;34(4):149-152.


Illinois Council of Health-System Pharmacists (ICHP)

Northern Illinois Society of Health-System Pharmacists

Society of Infectious Diseases Pharmacists (SIDP)

American College of Clinical Pharmacists (ACCP), HIV PRN and ID PRN

American Society of Health-System Pharmacists (ASHP)

American Academy of HIV Medicine (AAHIVM)


Shining Star Award, Illinois Society of Health-System Pharmacists - September 2019

Preceptor of the Year, Midwestern University Chicago College of Pharmacy - May 2018